HopeStage
Back to all studies
CompletedNCT05537584

Matching antidepressants to predict response to loss of pleasure

About this titleRead the official source — NCT05537584
Medication studyAges 18–64United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 64 years.

Listed locations
BelmontSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 30, 2022
Recruitment status
Completed
Enrollment listed in the registry
57
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT05537584
Official title
Show the full official title

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Sertraline and Bupropion.

Who was this study for?

Listed age limits: 18 years to 64 years.

Want to explore more studies?

Explore studies